Загрузка...
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
| Серии: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Предметы: | |
| Online-ссылка: | https://www.rpcardio.com/jour/article/view/820 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|